330 related articles for article (PubMed ID: 18250253)
1. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
[TBL] [Abstract][Full Text] [Related]
3. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
4. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.
Corlett PR; Honey GD; Aitken MR; Dickinson A; Shanks DR; Absalom AR; Lee M; Pomarol-Clotet E; Murray GK; McKenna PJ; Robbins TW; Bullmore ET; Fletcher PC
Arch Gen Psychiatry; 2006 Jun; 63(6):611-21. PubMed ID: 16754834
[TBL] [Abstract][Full Text] [Related]
5. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
[TBL] [Abstract][Full Text] [Related]
6. Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents.
Doyle OM; De Simoni S; Schwarz AJ; Brittain C; O'Daly OG; Williams SC; Mehta MA
J Pharmacol Exp Ther; 2013 Apr; 345(1):151-60. PubMed ID: 23370794
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
Shcherbinin S; Doyle O; Zelaya FO; de Simoni S; Mehta MA; Schwarz AJ
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4191-204. PubMed ID: 26223493
[TBL] [Abstract][Full Text] [Related]
8. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
[TBL] [Abstract][Full Text] [Related]
9. Negative emotionality shapes the modulatory effects of ketamine and lamotrigine in subregions of the anterior cingulate cortex.
Gärtner M; Weigand A; Meiering MS; Weigner D; Carstens L; Keicher C; Hertrampf R; Beckmann C; Mennes M; Wunder A; Grimm S
Transl Psychiatry; 2024 Jun; 14(1):258. PubMed ID: 38890270
[TBL] [Abstract][Full Text] [Related]
10. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
Petrakis IL; Limoncelli D; Gueorguieva R; Jatlow P; Boutros NN; Trevisan L; Gelernter J; Krystal JH
Am J Psychiatry; 2004 Oct; 161(10):1776-82. PubMed ID: 15465973
[TBL] [Abstract][Full Text] [Related]
11. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
[TBL] [Abstract][Full Text] [Related]
13. Temporal dynamics of the pharmacological MRI response to subanaesthetic ketamine in healthy volunteers: A simultaneous EEG/fMRI study.
McMillan R; Forsyth A; Campbell D; Malpas G; Maxwell E; Dukart J; Hipp JF; Muthukumaraswamy S
J Psychopharmacol; 2019 Feb; 33(2):219-229. PubMed ID: 30663520
[TBL] [Abstract][Full Text] [Related]
14. Plasma cyclic guanosine 3',5'-monophosphate levels: a marker of glutamate-nitric oxide-guanyl cyclase activity?
Engelhardt T; Zaarour C; Crawford MW
J Opioid Manag; 2011; 7(6):462-6. PubMed ID: 22320028
[TBL] [Abstract][Full Text] [Related]
15. Effects of ketamine on brain function during smooth pursuit eye movements.
Steffens M; Becker B; Neumann C; Kasparbauer AM; Meyhöfer I; Weber B; Mehta MA; Hurlemann R; Ettinger U
Hum Brain Mapp; 2016 Nov; 37(11):4047-4060. PubMed ID: 27342447
[TBL] [Abstract][Full Text] [Related]
16. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.
Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM
Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610
[TBL] [Abstract][Full Text] [Related]
17. Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities.
Li M; Demenescu LR; Colic L; Metzger CD; Heinze HJ; Steiner J; Speck O; Fejtova A; Salvadore G; Walter M
Neuropsychopharmacology; 2017 May; 42(6):1201-1209. PubMed ID: 27604568
[TBL] [Abstract][Full Text] [Related]
18. Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.
Dandash O; Harrison BJ; Adapa R; Gaillard R; Giorlando F; Wood SJ; Fletcher PC; Fornito A
Neuropsychopharmacology; 2015 Feb; 40(3):622-31. PubMed ID: 25141922
[TBL] [Abstract][Full Text] [Related]
19. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
[TBL] [Abstract][Full Text] [Related]
20. Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.
Joules R; Doyle OM; Schwarz AJ; O'Daly OG; Brammer M; Williams SC; Mehta MA
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4205-18. PubMed ID: 25980482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
